Abstract

Human plasmacytoid dendritic cells (pDCs) play a vital role in modulating immune responses. They can produce massive amounts of type I IFNs in response to nucleic acids via TLRs, but they are also known to possess weak Ag-presenting properties inducing CD4+ T cell activation. Previous studies showed a cross-regulation between TNF-α and IFN-α, but many questions remain about the effect of TNF-α in regulating human pDCs. In this study, we showed that TNF-α significantly inhibited the secretion of IFN-α and TNF-α of TLR-stimulated pDCs. Instead, exogenous TNF-α promoted pDC maturation by upregulating costimulatory molecules and chemokine receptors such as CD80, CD86, HLA-DR, and CCR7. Additionally, RNA sequencing analysis showed that TNF-α inhibited IFN-α and TNF-α production by downregulating IRF7 and NF-κB pathways, while it promoted Ag processing and presentation pathways as well as T cell activation and differentiation. Indeed, TNF-α-treated pDCs induced in vitro higher CD4+ T cell proliferation and activation, enhancing the production of Th1 and Th17 cytokines. In conclusion, TNF-α favors pDC maturation by switching their main role as IFN-α-producing cells to a more conventional dendritic cell phenotype. The functional status of pDCs might therefore be strongly influenced by their overall inflammatory environment, and TNF-α might regulate IFN-α-mediated aspects of a range of autoimmune and inflammatory diseases.

Highlights

  • TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN- α Production and Enhancing T Cell Activation

  • Peripheral blood plasmacytoid dendritic cells (pDCs) were analyzed by flow cytometry for the production of both IFN-a and TNF-a upon stimulation with TLR9 (ODN 2216) or TLR7 (ORN R-2336) agonists

  • The traditional pDC population is characterized by the expression of genes associated with pathogen sensing and induction of type I IFNs as well as the master regulator transcription factor TCF4 [48]

Read more

Summary

Materials and Methods

Human PBMCs were separated from whole blood by density gradient centrifugation using Leucosep tubes (Greiner Bio-One). Fluorochrome-conjugated mAbs against human CD3, CD4, CD19, CD14, CD56, CD11c, HLA-DR, CD123, CD303, CD317, CD80, CD85g, isotype controls (Miltenyi Biotec), CD304, CD69 (BioLegend), CD86, and CCR7 (BD Biosciences) were used. Measurement of Ag uptake pDCs were isolated from PBMCs (Miltenyi Biotec) and were cultured in RPMI medium 1640 with GlutaMAX supplement (Thermo Fisher Scientific) containing 10% (vol/vol) FBS and 100 U/ml penicillin/streptomycin in a 96well plate. Raw paired-end sequence data in Fastq format was initially analyzed using FastQC software to identify potential issues with data quality. Reads were aligned to human hg analysis set reference sequences, obtained from University of California Santa Cruz (UCSC) database [33] using splicing-aware STAR aligner [34] for RNA sequencing data. Error bars indicate SEM unless stated otherwise: *p , 0.05, **p , 0.01, ***p , 0.001, and ****p , 0.0001

Results
Discussion
Disclosures

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.